Molecular essence and treatment strategy of ER-negative/PgR-positive/HER2erhyphen;negative breast cancer

被引:0
|
作者
Yu, K.
Shao, Z.
机构
[1] Fudan Univ, Shanghai Med Coll, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China
来源
BREAST | 2015年 / 24卷
关键词
D O I
10.1016/S0960-9776(15)70161-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P119
引用
收藏
页码:S65 / S66
页数:2
相关论文
共 50 条
  • [31] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Ke-Da Yu
    Yi-Zhou Jiang
    Shuang Hao
    Zhi-Ming Shao
    BMC Medicine, 13
  • [32] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Hao, Shuang
    Shao, Zhi-Ming
    BMC MEDICINE, 2015, 13
  • [33] Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer
    Kubo, Makoto
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [34] Expression of hormone receptors ERα, ERβ and PgR in HER-2-positive breast cancer
    Litwiniuk, Maria
    WSPOTCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (05): : 235 - 239
  • [35] Developmental and therapeutic implications of molecular profiles of ER-positive and ER-negative breast cancers.
    Perou, CM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S3 - S3
  • [36] Biology and prognosis of HER2-negative breast cancer with low-ER and PgR-expressions.
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Okumura, Yasuhiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Restoration of ER expression and antiestrogen response in ER-negative breast cancer
    Bayliss, Jill
    Hilger, Amy
    El-Ashry, Dorraya
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Monitoring total hemoglobin concentration changes across neoadjuvant chemotherapy in PgR-positive and PgR-negative breast cancer with Diffuse Optical Tomography
    Altoe, Mirella L.
    Marone, Alessandro
    Kim, Hyun K.
    Tejada, Mariella
    Hibshoosh, Hanina
    Crew, Katherine
    Kalinsky, Kevin
    Hershman, Dawn L.
    Hielscher, Andreas H.
    OPTICAL TOMOGRAPHY AND SPECTROSCOPY OF TISSUE XIII, 2019, 10874
  • [39] Response to: Is there any association between a delay in surgery and nodal positivity in the ER-negative Her2 negative breast cancer subgroups?
    Khader, Adam
    Fischer, Trevan
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (01) : 155 - 155
  • [40] New Treatment Options in ER-Positive, HER2-Positive and Triple-Negative Breast Cancer
    Steger, Guenther
    Bell, Richard
    Cameron, David
    Dent, Rebecca A.
    Jackisch, Christian
    BREAST CARE, 2013, 8 (02) : 155 - 157